Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - PARP - Senaparib

Senaparib

CAS No. 1401682-78-7

Senaparib( IMP4297 )

Catalog No. M28788 CAS No. 1401682-78-7

Senaparib is a novel highly potent and selective oral PARP1/2 inhibitor with strong antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 Get Quote
5MG 80 Get Quote
10MG 140 Get Quote
25MG 260 Get Quote
50MG 410 Get Quote
100MG 605 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Senaparib
  • Note
    Research use only, not for human use.
  • Brief Description
    Senaparib is a novel highly potent and selective oral PARP1/2 inhibitor with strong antitumor activity.
  • Description
    Senaparib is a novel highly potent and selective oral PARP1/2 inhibitor with strong antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    IMP4297
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    neuropeptide Y (NPY) Y1 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1401682-78-7
  • Formula Weight
    478.45
  • Molecular Formula
    C24H20F2N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (174.17 mM)
  • SMILES
    O=C(c(cc(CN(c1cccc(F)c1C(N1)=O)C1=O)cc1)c1F)N(CC1)CCN1c1ncccn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Antal-Zimanyi I, et al. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist. Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Rucaparib Camsylate

    Rucaparib Camsylate is a PARP inhibitor (PARP1,Ki of 1.4 nM). Rucaparib Camsylate also displays binding affinity to eight other PARP domains. Rucaparib is the most effective PARP inhibitor in enzyme assays (Ki: 1.4 nM). Rucaparib inhibits PARP-1 activity by 97.1% at a concentration of 1 μM in permeabilized D283Med cells.

  • BGP-15

    A PARP inhibitor and an inducer of HSF-1/HSP72 (cotreatment with heat) in vtiro.

  • UNBS-5162

    UNBS-5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.

Sign In Join Free